Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Fred's Inc.’s ( FRED - Analyst Report ) third quarter 2012 earnings of 18 cents declined 25% from the prior-year quarter earnings of 24 cents. Earnings also missed the Zacks Consensus Estimate of 21 cents and the company guidance range of 22 cents to 26 cents. The ongoing tough retail environment and higher operating expenses also led to the decline.
Revenue and Margin Performance
Total sales increased 1% year over year to $450.6 million, in line with the Zacks Consensus Estimate. Despite a decline in comparable sales, Fred’s exhibited positive growth on the back of higher merchandise sales and improved consumer traffic, resulting from marketing initiatives. Fred’s comparable store sales slipped 2.5% during the quarter compared to a 1.5% rise in the year-ago quarter.
Gross profits grew 2% to $138.1 million while gross margin expanded 10 basis points to 30.7% from the year-ago quarter. The improved margin was the result of higher pharmacy department gross margin, partially offset by increased charges on pharmacy department inventory, as well as promotional markdowns and shrinkage.
Selling, general and administrative expense margin increased 90 basis points to 28.5% in the quarter, due to higher depreciation and amortization expenses and labor and occupancy costs.
Operating income plummeted 25.7% to $10.1 million in the quarter while margins shrank 80 basis points to 2.2% of sales due to higher operating expenses.
Other Financial Update
Fred's board declared a special dividend of 19 cents per share in the quarter, in addition to the company's regular quarterly dividend of 6 cents per share. The combined dividend of 25 cents will be paid on December 17, 2012, to shareholders as of December 3, 2012.
Guidance
Management expects tough retail conditions to continue across the markets in fiscal 2012. For the fourth quarter of 2012, Fred’s forecasts its total sales, including one extra week, to increase 9% to 11%.
Comparable store sales, including one extra week, are expected to increase 6% to 8%. The company expects earnings to increase in a range of 19% to 38% and remain within a range of 31 cents - 36 cents per share in the fourth quarter of 2012.
Fred’s lowered its 2012 earnings guidance to a range of 94 cents to 99 cents per share from 97 cents to $1.04 per share forecasted earlier.
The Zacks Consensus Estimate is pegged at earnings of 32 cents for the fourth quarter and 96 cents for fiscal 2012.
We currently have a long-term Neutral recommendation on Fred’s. The stock carries a Zacks #3 Rank (a short-term Hold rating). Its peers, Dollar General Corporation ( DG - Snapshot Report ) and Wal-Mart Stores Inc. ( WMT - Analyst Report ) , both carry a Zacks #3 Rank (short-term Hold rating).
Read the full Analyst Report on FRED
Read the full Analyst Report on WMT
Read the full Snapshot Report on DG